Adverse Events During Hemodialysis in LVAD Recipients
Over the past decade, implantable left ventricular assist devices (LVAD) have become an acceptable alternative to support patients with advanced heart failure, either as a bridge to transplantation or as destination therapy for patients who are not candidates for heart transplantation. As the number of LVAD implantation increases, greater number of LVAD recipients requiring long term renal replacement therapy (RRT), usually chronic hemodialysis (HD), will be seen. This is due to common simultaneous chronic kidney disease in patients with heart failure, but more frequently due to irreversible acute kidney injury occurring in the peri-implantation period.
Source: Journal of Cardiac Failure - Category: Cardiology Authors: Tapati Stalam, Ami Patel Tags: 236 Source Type: research
More News: Cardiology | Chronic Kidney Disease | Dialysis | Heart | Heart Failure | Heart Transplant | Hemodialysis | Kidney Transplant | Kidney Transplantation | Transplants | Urology & Nephrology